Status:

UNKNOWN

Modulation of Gut Microbiota to Enhance Health and Immunity

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Gut Microbiota

COVID-19 Vaccine

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The novel coronavirus infection (COVID-19) caused by the SARS-CoV-2 virus is now a pandemic and has culminated major morbidity and mortality globally. Studies have shown that patients with underlying ...

Detailed Description

HYPOTHESIS We hypothesize that modulating the gut microbiota with a microbiome immunity formula can rebalance the gut microbiota in populations at risk of infection, like, patients with type 2 DM and ...

Eligibility Criteria

Inclusion

  • Substudy 1
  • Age 18 years - below 65 years
  • A confirmed diagnosis of type 2 DM for ≥ 3 months with stable control (i.e. no change in DM medications in recent 2 months)
  • Written informed consents obtained

Exclusion

  • Known history of confirmed COVID-19 infection
  • Known active sepsis or active malignancy
  • Known increased infection risk due to underlying immunosuppressed state which includes:
  • Prior organ or hematopoietic stem cell transplant
  • Neutropenia with absolute neutrophil count (ANC) \<500 cells/ul at the time of study inclusion
  • Known HIV infection with CD4 \<200 cells/ul at the time of study inclusion
  • On concomitant immunosuppressants or corticosteroid at a dose of prednisolone equivalent dose 10mg or more for more than 3 months
  • Known history or active infective endocarditis
  • On peritoneal dialysis or haemodialysis
  • Documented pregnancy
  • Substudy 2
  • Inclusion Criteria:
  • Age 65 years and above
  • Written informed consents obtained

Key Trial Info

Start Date :

June 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2024

Estimated Enrollment :

453 Patients enrolled

Trial Details

Trial ID

NCT04884776

Start Date

June 1 2021

End Date

May 31 2024

Last Update

December 29 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital, Shatin

Hong Kong, Hong Kong